PRESS RELEASES

Gregory Oakes Named as President and Chief Executive Officer of Landos Biopharma

Chartwell Partners is pleased to have worked with public, clinical stage, autoimmune disease focused biopharmaceutical company, Landos Biopharma, to recruit Greg Oakes as President and Chief Executive Officer. Mr. Oakes brings a wealth of experience building and leading organizations through the development and commercialization of life changing medicines. He most recently served as President, North America, Executive Vice President and member of the Executive Committee of Vifor Pharma. Prior to that position, he served as Corporate Vice President and Global Integration Lead for Otezla® at Amgen from 2019 to 2020, overseeing the integration of the $2 billion brand acquired from Celgene, and positioning it for sustained growth. Mr. Oakes was Corporate Vice President and General Manager, US for Celgene’s Inflammation and Immunology franchise. He held earlier leadership roles at Amgen, Novartis International AG and Schering-Plough (Merck). Mr. Oakes brings more than 25 years of pharmaceutical industry experience leading development stage programs through to successful commercialization.